Insider Transactions in Q3 2021 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.8%
|
$375,000
$25.84 P/Share
|
|
Sep 13
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.52%
|
$390,000
$26.25 P/Share
|
|
Aug 12
2021
|
Hsiao D Lieu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-100.0%
|
$184,000
$23.5 P/Share
|
|
Aug 12
2021
|
Hsiao D Lieu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$96,000
$12.06 P/Share
|
|
Aug 11
2021
|
Hsiao D Lieu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,258
-100.0%
|
$51,934
$23.0 P/Share
|
|
Aug 10
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.54%
|
$345,000
$23.15 P/Share
|
|
Aug 09
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.51%
|
$360,000
$24.85 P/Share
|